3 results match your criteria: "Neurofibromatosis type 2 clinic[Affiliation]"
Clinical response associated with radiographic regression of a cervicomedullary ependymoma in a NF2 patient treated by bevacizumab.
J Neurooncol
November 2015
Department of Neurosurgery, Neurofibromatosis type 2 Clinic of Ile de France, Neurofibromatosis Reference Center, Pitié-Salpêtrière Hospital, AP-HP, 75013, Paris, France.
Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features.
Neuro Oncol
August 2012
Department of Neurosurgery, Neurofibromatosis type 2 clinic, Hôpital Beaujon, Assistance Publique Hôpitaux de Paris, Clichy, France.
Decision-making criteria for optimal management of meningiomas in neurofibromatosis type 2 (NF2) patients is hampered by lack of robust data, particularly long-term natural history. Seventy-four NF2 patients harboring 287 cranial meningiomas followed up for a mean period of 110.2 months were studied retrospectively.
View Article and Find Full Text PDFRadiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab.
Ann Oncol
April 2011
Department of Neurosurgery, Neurofibromatosis type 2 Clinic of Ile de France Neurofibromatosis Reference Centre, Hôpital Beaujon, Assistance Publique Hôpitaux de Paris; INSERM U674; Faculty of Medicine, Université Paris 7 - Denis Diderot. Electronic address: